CTOs on the Move

American Hospital Service Group

www.ahsg.us

 
American Hospital Service Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.ahsg.us
  • 415 Eagleview Blvd Ste 108
    Exton, PA USA 19341
  • Phone: 610.524.2400

Executives

Name Title Contact Details

Similar Companies

Ameriplan

Ameriplan is a Foley, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Master Spas

Master Spas is an award-winning hot tub and swim spa manufacturer. All of our hot tub, swim spas and portable spas are full of top-of-the-line features and healing hydrotherapy.

Genomics Institute of the Novartis Research Foundation (GNF)

Genomics Institute of the Novartis Research Foundation (GNF) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orthopaedic Associates of Muskegon

Orthopaedic Associates of Muskegon is a medical practice that specializes in orthopedic care for patients of all ages, from pediatrics to geriatrics. They offer non-invasive treatment options such as electro stimulation, nutrition, new medications, and...

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.